163 related articles for article (PubMed ID: 16256023)
21. Natural killer cell functional activity suppression by intravenous immunoglobulin, intralipid and soluble human leukocyte antigen-G.
Roussev RG; Ng SC; Coulam CB
Am J Reprod Immunol; 2007 Apr; 57(4):262-9. PubMed ID: 17362387
[TBL] [Abstract][Full Text] [Related]
22. HLA-G1 co-expression boosts the HLA class I-mediated NK lysis inhibition.
Riteau B; Menier C; Khalil-Daher I; Martinozzi S; Pla M; Dausset J; Carosella ED; Rouas-Freiss N
Int Immunol; 2001 Feb; 13(2):193-201. PubMed ID: 11157852
[TBL] [Abstract][Full Text] [Related]
23. The possible use of HLA-G1 and G3 in the inhibition of NK cell-mediated swine endothelial cell lysis.
Matsunami K; Miyagawa S; Nakai R; Murase A; Shirakura R
Clin Exp Immunol; 2001 Oct; 126(1):165-72. PubMed ID: 11678914
[TBL] [Abstract][Full Text] [Related]
24. Residues Met76 and Gln79 in HLA-G alpha1 domain involve in KIR2DL4 recognition.
Yan WH; Fan LA
Cell Res; 2005 Mar; 15(3):176-82. PubMed ID: 15780179
[TBL] [Abstract][Full Text] [Related]
25. Ocular surface epithelial cells up-regulate HLA-G when expanded in vitro on amniotic membrane substrates.
Higa K; Shimmura S; Shimazaki J; Tsubota K
Cornea; 2006 Jul; 25(6):715-21. PubMed ID: 17077667
[TBL] [Abstract][Full Text] [Related]
26. HLA-G1-transfected K562 cells do not inhibit NK-cell-mediated lysis in europium release cytotoxicity assay.
Sapak M; Buc M
Bratisl Lek Listy; 2003; 104(10):300-4. PubMed ID: 15055728
[TBL] [Abstract][Full Text] [Related]
27. Porcine aortic endothelial cells transfected with HLA-G are partially protected from xenogeneic human NK cytotoxicity.
Forte P; Matter-Reissmann UB; Strasser M; Schneider MK; Seebach JD
Hum Immunol; 2000 Nov; 61(11):1066-73. PubMed ID: 11137209
[TBL] [Abstract][Full Text] [Related]
28. MICA triggering signal for NK cell tumor lysis is counteracted by HLA-G1-mediated inhibitory signal.
Menier C; Riteau B; Carosella ED; Rouas-Freiss N
Int J Cancer; 2002 Jul; 100(1):63-70. PubMed ID: 12115588
[TBL] [Abstract][Full Text] [Related]
29. [Establishment of eukaryotic cell line stably expressing soluble human leucocyte antigen G1 by nucleofection].
Zeng M; Fang C; Wang S
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2006 Nov; 20(11):1130-3. PubMed ID: 17191583
[TBL] [Abstract][Full Text] [Related]
30. HLA-G*0105N null allele encodes functional HLA-G isoforms.
Le Discorde M; Le Danff C; Moreau P; Rouas-Freiss N; Carosella ED
Biol Reprod; 2005 Aug; 73(2):280-8. PubMed ID: 15814900
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of miR-152 leads to reduced expression of human leukocyte antigen-G and increased natural killer cell mediated cytolysis in JEG-3 cells.
Zhu XM; Han T; Wang XH; Li YH; Yang HG; Luo YN; Yin GW; Yao YQ
Am J Obstet Gynecol; 2010 Jun; 202(6):592.e1-7. PubMed ID: 20430358
[TBL] [Abstract][Full Text] [Related]
32. Modulation of the leader peptide sequence of the HLA-E gene up-regulates its expression and down-regulates natural killer cell-mediated swine endothelial cell lysis.
Matsunami K; Miyagawa S; Nakai R; Yamada M; Shirakura R
Transplantation; 2002 May; 73(10):1582-9. PubMed ID: 12042643
[TBL] [Abstract][Full Text] [Related]
33. HLA-E/human beta2-microglobulin transgenic pigs: protection against xenogeneic human anti-pig natural killer cell cytotoxicity.
Weiss EH; Lilienfeld BG; Müller S; Müller E; Herbach N; Kessler B; Wanke R; Schwinzer R; Seebach JD; Wolf E; Brem G
Transplantation; 2009 Jan; 87(1):35-43. PubMed ID: 19136889
[TBL] [Abstract][Full Text] [Related]
34. The immunotolerance role of HLA-G.
Rouas-Freiss N; Khalil-Daher I; Riteau B; Menier C; Paul P; Dausset J; Carosella ED
Semin Cancer Biol; 1999 Feb; 9(1):3-12. PubMed ID: 10092545
[TBL] [Abstract][Full Text] [Related]
35. [Immune tolerance inducing effects of soluble human leucocyte antigen G1 on natural killer cells and T cells].
Fang CY; Wu XW; Liang ZH; Chen H; Han JY; Huang YF; Gong FL
Zhonghua Yi Xue Za Zhi; 2003 Apr; 83(7):584-7. PubMed ID: 12887750
[TBL] [Abstract][Full Text] [Related]
36. [Construction of eukaryotic expression plasmid expressing siRNA targeting HLA-G gene and detection of its specific downregulation effect].
Chen JH; Yao YQ; Hou KB; Lei YF; Yin W
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 May; 23(5):409-12. PubMed ID: 17488599
[TBL] [Abstract][Full Text] [Related]
37. Immunosuppressive effects of mesenchymal stem cells: involvement of HLA-G.
Nasef A; Mathieu N; Chapel A; Frick J; François S; Mazurier C; Boutarfa A; Bouchet S; Gorin NC; Thierry D; Fouillard L
Transplantation; 2007 Jul; 84(2):231-7. PubMed ID: 17667815
[TBL] [Abstract][Full Text] [Related]
38. Increased frequency of human leukocyte antigen-E inhibitory receptor CD94/NKG2A-expressing peritoneal natural killer cells in patients with endometriosis.
Galandrini R; Porpora MG; Stoppacciaro A; Micucci F; Capuano C; Tassi I; Di Felice A; Benedetti-Panici P; Santoni A
Fertil Steril; 2008 May; 89(5 Suppl):1490-6. PubMed ID: 17706207
[TBL] [Abstract][Full Text] [Related]
39. The role of peptide presentation in the physiological function of HLA-G.
Münz C; Nickolaus P; Lammert E; Pascolo S; Stevanović S; Rammensee HG
Semin Cancer Biol; 1999 Feb; 9(1):47-54. PubMed ID: 10092550
[TBL] [Abstract][Full Text] [Related]
40. NK resistance of tumor cells from multiple myeloma and chronic lymphocytic leukemia patients: implication of HLA-G.
Maki G; Hayes GM; Naji A; Tyler T; Carosella ED; Rouas-Freiss N; Gregory SA
Leukemia; 2008 May; 22(5):998-1006. PubMed ID: 18288133
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
